Third dose of vaccine enhances antibody response, particularly among older adults

A manuscript from a CITF-funded study in preprint (not yet peer-reviewed) by Drs. Marc Romney (University of British Columbia), Zabrina Brumme and Mark Brockman (Simon Fraser University), demonstrated that a third dose of an mRNA vaccine significantly enhanced the magnitude and durability of antibody responses, including among older adults (>70 years old) who remained COVID-naïve.